chr17-63917428-C-G

Variant summary

Our verdict is Likely benign. Variant got -3 ACMG points: 0P and 3B. BP4_ModerateBS1_Supporting

The NM_000515.5(GH1):ā€‹c.535G>Cā€‹(p.Asp179His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000345 in 1,613,952 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.00020 ( 0 hom., cov: 32)
Exomes š‘“: 0.00036 ( 0 hom. )

Consequence

GH1
NM_000515.5 missense

Scores

1
2
15

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: 1.46
Variant links:
Genes affected
GH1 (HGNC:4261): (growth hormone 1) The protein encoded by this gene is a member of the somatotropin/prolactin family of hormones which play an important role in growth control. The gene, along with four other related genes, is located at the growth hormone locus on chromosome 17 where they are interspersed in the same transcriptional orientation; an arrangement which is thought to have evolved by a series of gene duplications. The five genes share a remarkably high degree of sequence identity. Alternative splicing generates additional isoforms of each of the five growth hormones, leading to further diversity and potential for specialization. This particular family member is expressed in the pituitary but not in placental tissue as is the case for the other four genes in the growth hormone locus. Mutations in or deletions of the gene lead to growth hormone deficiency and short stature. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -3 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.13372788).
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.000204 (31/152278) while in subpopulation NFE AF= 0.000368 (25/68026). AF 95% confidence interval is 0.000255. There are 0 homozygotes in gnomad4. There are 14 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
GH1NM_000515.5 linkuse as main transcriptc.535G>C p.Asp179His missense_variant 5/5 ENST00000323322.10
LOC112268204XR_002958148.2 linkuse as main transcriptn.341-169C>G intron_variant, non_coding_transcript_variant
GH1NM_022559.4 linkuse as main transcriptc.490G>C p.Asp164His missense_variant 5/5
GH1NM_022560.4 linkuse as main transcriptc.415G>C p.Asp139His missense_variant 4/4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
GH1ENST00000323322.10 linkuse as main transcriptc.535G>C p.Asp179His missense_variant 5/51 NM_000515.5 P1P01241-1

Frequencies

GnomAD3 genomes
AF:
0.000204
AC:
31
AN:
152160
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000367
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000131
AC:
33
AN:
251168
Hom.:
0
AF XY:
0.000118
AC XY:
16
AN XY:
135734
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000264
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000360
AC:
526
AN:
1461674
Hom.:
0
Cov.:
31
AF XY:
0.000355
AC XY:
258
AN XY:
727144
show subpopulations
Gnomad4 AFR exome
AF:
0.000120
Gnomad4 AMR exome
AF:
0.0000671
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.0000348
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000444
Gnomad4 OTH exome
AF:
0.000331
GnomAD4 genome
AF:
0.000204
AC:
31
AN:
152278
Hom.:
0
Cov.:
32
AF XY:
0.000188
AC XY:
14
AN XY:
74468
show subpopulations
Gnomad4 AFR
AF:
0.000120
Gnomad4 AMR
AF:
0.0000653
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000368
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000268
Hom.:
0
Bravo
AF:
0.000212
ExAC
AF:
0.000115
AC:
14
EpiCase
AF:
0.000218
EpiControl
AF:
0.000237

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpAug 15, 2022In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change affects GH1 function (PMID: 18785993). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 891323). This missense change has been observed in individual(s) with autosomal dominant growth hormone deficiency (PMID: 18785993). This variant is present in population databases (rs151243538, gnomAD 0.02%). This sequence change replaces aspartic acid, which is acidic and polar, with histidine, which is basic and polar, at codon 179 of the GH1 protein (p.Asp179His). -
Uncertain significance, criteria provided, single submitterclinical testingGeneDxDec 27, 2022Identified in the heterozygous state in one individual with partial IGHD, but segregation data is limited (de Graaff et al., 2009); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Also known as p.(D153H); This variant is associated with the following publications: (PMID: 18785993) -
Decreased response to growth hormone stimulation test Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 28, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Benign
-0.28
CADD
Benign
6.0
DANN
Benign
0.26
DEOGEN2
Pathogenic
0.84
.;.;D;D
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.073
N
LIST_S2
Benign
0.71
T;T;T;T
M_CAP
Uncertain
0.090
D
MetaRNN
Benign
0.13
T;T;T;T
MetaSVM
Benign
-0.39
T
MutationTaster
Benign
0.56
D;N;N;N;N
PrimateAI
Benign
0.40
T
PROVEAN
Uncertain
-3.4
D;D;D;D
REVEL
Benign
0.28
Sift
Benign
0.16
T;T;T;T
Sift4G
Benign
0.17
T;T;T;T
Polyphen
0.014, 0.0040
.;.;B;B
Vest4
0.15
MVP
0.65
MPC
0.16
ClinPred
0.024
T
GERP RS
-2.4
Varity_R
0.27
gMVP
0.45

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs151243538; hg19: chr17-61994788; COSMIC: COSV60110336; COSMIC: COSV60110336; API